CBD Research

Home > CBD Research

We believe medical research needs to be expanded to include the voice of the citizen scientist while keeping pace with the rise of disease and the need for more natural solutions. In the ARISS 1 and ARISS 2 study series, we conducted original research on the clinical effects of PCR Hemp Oil–and the results were surprising:

Reduction in use of alcohol to control anxiety?

Probable modulation of the gut-brain axis?

“I don’t have anxiety anymore… I’m much more able to just let it go.”

— ARISS Study Participant.

Why is this important?

0

PERCENT OF AMERICANS WILL HAVE A MENTAL ILLNESS THIS YEAR

0

PERCENT OF ADULTS REPORT A LOT OF PAIN ON A CHRONIC BASIS

0

PERCENT OF AMERICANS SUFFER FROM SLEEPLESSNESS

ARISS 1 Hemp Study

For the ARISS 1 Study, we relied upon 60 patients from our practice to help us understand PCR Hemp Oil and it’s affect on pain, anxiety, insomnia, IBS, and eczema.

We saw a significant decrease in headaches, pain and stiffness, anxiety, and eczema.

36%

reduction in alcohol consumption

50%

reduction in NSAID use

Review of ARISS 1 : Video with Dr. Miller

ARISS 1 Full Report Document

ARISS 2 Hemp Study

For the ARISS 2 study, we selected 30 patients from our practice to participate in a clinical trial that explored PCR Hemp Oil and its effect on anxiety, insomnia, and IBS.

With the help of 4 amazing laboratory partners, we were able to gather testing data from each patient to take a deeper look at the anxiety-insomnia-IBS triad.

Dr. Miller’s Hypothesis

This research was conducted in partnership with Foliuim Biosciences, a global leader in the PCR Hemp Oil industry

Study Lab Partners